Supernus Pharmaceuticals, Inc.
SUPN· Nasdaq
SUPNSupernus Pharmaceuticals, Inc.
Quarterly figures for Supernus Pharmaceuticals, Inc., with source filings when available.
62 quarters. Mar 31, 2011 to Jun 30, 2026. USD.
Supernus Pharmaceuticals, Inc. has filed its 10-Q within 34 to 38 days of period end across its last 8 quarters. The 10-K runs 56 to 103 days.
Supernus Pharmaceuticals, Inc. · CIK 1356576 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 3, 2026 · market hours | Aug 3, 2026 | 34 d | 10-Q | $219.06M | +32.4% | -$1.01 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 5, 2026 · after-hours |
| May 5, 2026 |
| 35 d |
| 10-Q |
| $207.71M |
| +38.6% |
| -$0.04 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 24, 2026 · after-hours | Mar 2, 2026 | 61 d | 10-K | $211.57M | +21.5% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 · after-hours | Nov 6, 2025 | 37 d | 10-Q | $192.10M | +9.3% | -$0.80 | |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 · after-hours | Aug 5, 2025 | 36 d | 10-Q | $165.45M | −1.7% | $0.40 | |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · after-hours | May 6, 2025 | 36 d | 10-Q | $149.82M | +4.3% | -$0.21 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 25, 2025 · after-hours | Feb 25, 2025 | 56 d | 10-K | $174.16M | +6.0% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 4, 2024 · after-hours | Nov 4, 2024 | 35 d | 10-Q | $175.69M | +14.2% | $0.69 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · after-hours | Aug 6, 2024 | 37 d | 10-Q | $168.33M | +24.2% | $0.36 | |
| Q1 2024 | Mar 31, 2024 | May 8, 2024 · after-hours | May 8, 2024 | 38 d | 10-Q | $143.64M | −6.6% | $0.00 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 27, 2024 · after-hours | Feb 27, 2024 | 58 d | 10-K | $164.31M | −1.8% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 · after-hours | Nov 8, 2023 | 39 d | 10-Q | $153.88M | −13.2% | -$0.29 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · after-hours | Aug 8, 2023 | 39 d | 10-Q | $135.56M | −20.3% | -$0.02 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · after-hours | May 9, 2023 | 39 d | 10-Q | $153.76M | +0.8% | $0.29 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 28, 2023 · after-hours | Mar 9, 2023 | 68 d | 10-K | $167.33M | +5.2% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · after-hours | Nov 9, 2022 | 40 d | 10-Q | $177.35M | +19.5% | $0.03 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · after-hours | Aug 8, 2022 | 39 d | 10-Q | $170.05M | +20.3% | $0.14 | |
| Q1 2022 | Mar 31, 2022 | May 9, 2022 · after-hours | May 12, 2022 | 42 d | 10-Q | $152.51M | +16.5% | $0.43 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 28, 2022 · after-hours | Apr 13, 2022 | 103 d | 10-K | $159.05M | +10.8% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 5, 2021 | 36 d | 10-Q | $148.46M | −4.3% | $0.40 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 6, 2021 | 37 d | 10-Q | $141.33M | +11.5% | $0.43 | |
| Q1 2021 | Mar 31, 2021 | — | May 7, 2021 | 37 d | 10-Q | $130.93M | +37.9% | $0.11 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 8, 2021 | 67 d | 10-K | $143.56M | +42.9% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 6, 2020 | 37 d | 10-Q | $155.14M | +51.9% | $0.74 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 17, 2020 | 48 d | 10-Q | $126.73M | +21.0% | $0.65 | |
| Q1 2020 | Mar 31, 2020 | — | May 15, 2020 | 45 d | 10-Q | $94.98M | +11.1% | $0.40 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Feb 28, 2020 | 59 d | 10-K | $100.45M | −13.4% | $0.62 | |
| Q3 2019 | Sep 30, 2019 | — | Nov 8, 2019 | 39 d | 10-Q | $102.14M | −0.8% | $0.54 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 9, 2019 | 40 d | 10-Q | $104.70M | +5.2% | $0.61 | |
| Q1 2019 | Mar 31, 2019 | — | May 10, 2019 | 40 d | 10-Q | $85.47M | −5.5% | $0.34 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | Mar 1, 2019 | 60 d | 10-K | $115.93M | +31.1% | $0.48 | |
| Q3 2018 | Sep 30, 2018 | — | Nov 9, 2018 | 40 d | 10-Q | $103.00M | +28.1% | $0.52 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 9, 2018 | 40 d | 10-Q | $99.54M | +31.3% | $0.57 | |
| Q1 2018 | Mar 31, 2018 | — | May 10, 2018 | 40 d | 10-Q | $90.43M | +57.1% | $0.49 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Mar 1, 2018 | 60 d | 10-K | $88.44M | +41.8% | $0.26 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 9, 2017 | 40 d | 10-Q | $80.40M | +41.5% | $0.29 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 3, 2017 | 34 d | 10-Q | $75.83M | +46.9% | $0.32 | |
| Q1 2017 | Mar 31, 2017 | — | May 9, 2017 | 39 d | 10-Q | $57.58M | +30.3% | $0.19 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 16, 2017 | 75 d | 10-K | $62.37M | +42.8% | $0.26 | |
| Q3 2016 | Sep 30, 2016 | — | Jan 20, 2017 | 112 d | 10-Q | $56.81M | +44.3% | $1.18 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 5, 2016 | 36 d | 10-Q | $51.63M | +44.7% | $0.18 | |
| Q1 2016 | Mar 31, 2016 | — | May 10, 2016 | 40 d | 10-Q | $44.19M | +53.8% | $0.08 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Mar 9, 2016 | 69 d | 10-K | $43.69M | +39.9% | $0.14 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 9, 2015 | 40 d | 10-Q | $39.36M | +73.5% | $0.08 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 7, 2015 | 38 d | 10-Q | $35.68M | +20.2% | $0.04 | |
| Q1 2015 | Mar 31, 2015 | — | May 6, 2015 | 36 d | 10-Q | $28.74M | +216.5% | $0.02 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | Mar 12, 2015 | 71 d | 10-K | $31.24M | +202.3% | $0.09 | |
| Q3 2014 | Sep 30, 2014 | — | Nov 12, 2014 | 43 d | 10-Q | $22.69M | +1,704.9% | -$0.06 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 12, 2014 | 43 d | 10-Q | $29.68M | +10,460.5% | $0.08 | |
| Q1 2014 | Mar 31, 2014 | — | May 13, 2014 | 43 d | 10-Q | $9.08M | +6,077.6% | -$0.38 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | Mar 21, 2014 | 80 d | 10-K | $10.33M | +848.1% | -$0.65 | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $1.26M | +1,281.3% | -$0.78 | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $281.00K | +208.8% | -$0.89 | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $147.00K | −29.3% | -$0.60 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | — | — | — | $1.09M | +2,495.2% | -$0.51 | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $91.00K | +727.3% | -$0.55 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $91.00K | −87.9% | -$0.61 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $208.00K | — | -$6.05 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2011 | — | — | — | — | $42.00K | — | $2.34 | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $11.00K | — | -$6.90 | |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $750.00K | — | -$6.15 | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | — | — | -$6.64 | |
